0001214659-19-006703.txt : 20191029 0001214659-19-006703.hdr.sgml : 20191029 20191029200821 ACCESSION NUMBER: 0001214659-19-006703 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191025 FILED AS OF DATE: 20191029 DATE AS OF CHANGE: 20191029 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chang David D CENTRAL INDEX KEY: 0001611024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 191177023 MAIL ADDRESS: STREET 1: C/O ALLOGENE THERAPEUTICS, INC. STREET 2: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-45997.xml PRIMARY DOCUMENT X0306 4 2019-10-25 0001737287 Allogene Therapeutics, Inc. ALLO 0001611024 Chang David D 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true true false false President and CEO Common Stock 2019-10-25 4 J false 9402 0.00 A 1173106 I See footnote Common Stock 2019-10-25 4 J false 9391 0.00 A 2215354 D Pro rata distribution of shares of the Issuer's common stock from VVAG Special Fund LLC (VVAG) to its members pursuant to a Rule 10b5-1 trading plan adopted by VVAG on March 29, 2019. Securities held in the name of the Chang 2006 Family Trust. Pro rata distribution of shares of the Issuer's common stock from VVAG LLC to its members. /s/ Veer Bhavnagri, Attorney-in-Fact 2019-10-29